Visible disease at baseline accelerates time to exit from MRI-based active surveillance
暂无分享,去创建一个
A. Freeman | S. Punwani | F. Giganti | V. Stavrinides | C. Moore | M. Emberton | C. Orczyk | H. Whitaker | C. Allen | A. Kirkham
暂无分享,去创建一个
A. Freeman | S. Punwani | F. Giganti | V. Stavrinides | C. Moore | M. Emberton | C. Orczyk | H. Whitaker | C. Allen | A. Kirkham